Apple highlights ‘ResearchKit’ through watch launch
March 10, 2015Medical Communications, Sales and Marketing Apple, FDA, digital, health, healthkit, researchkit, wearables
US tech giant Apple has finally launched its digital wearable device along with a ResearchKit platform that allows apps to …
Oncologists say CDF cuts will compromise treatment
March 10, 2015Sales and Marketing CDF, Jevtana, NHS, NICE, Sanofi, cabazitaxel, doctors.net, m3
Oncologists believe cutting drugs from the Cancer Drugs Fund won’t save the NHS money and will worsen patient outcomes according …
Sanofi names audit committee chairman
March 10, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Robert Castaigne, Sanofi
Sanofi has looked to its own board to fulfil the role of chairman as it names Robert Castaigne chairman of …
Targacept and Catalyst sign $100 million deal
March 9, 2015Research and Development, Sales and Marketing CB 813d, PF-05280602, Targecept, blood disorder, catalyst biosciences
Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …
Novo Nordisk obesity drug shows added benefits
March 9, 2015Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight
New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …
FDA approves new anti-fungal treatment
March 9, 2015Sales and Marketing Astellas, Basilea, FDA, US, cresemba, isavuconazonium sulfate, zygomycosis
The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …
Fixing what’s broken: why companies must prioritise innovation in drug development
March 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, The Institute of Cancer Research, innovation, oncology, paul workman
The global system for discovering new cancer drugs is broken. It is failing to turn dramatic scientific advances into enough …
ESSA Pharma appoints independent director
March 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing essa pharma, franklin berger
US pharma development firm ESSA Pharma has appointed Franklin Berger as an independent director. A resident of New York, Berger’s …
Merck and NewLink Ebola vaccine trial begins
March 6, 2015Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV
Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …
Novartis secures first US biosimilar product
March 6, 2015Research and Development, Sales and Marketing Amgen, Cancer, FDA, Neupogen, Novartis, Sandoz, Zarxio, biosimilar, filgrastim-sndz
Novartis’ generic arm Sandoz has won the race to become the first company to market a biosimilar in the US …
Merck and Eisai partner on cancer therapy trial
March 6, 2015Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1
Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …
FDA launches drug shortages app
March 6, 2015Medical Communications, Sales and Marketing Apple, FDA, app, drug, google, play, recall, shortages
The US Food and Drug Administration has launched its first smartphone app which provides valuable information about drug shortages. The …
Anti-blood clotting drug Eliquis gets NICE nod
March 6, 2015Sales and Marketing BMS, DVT, Eliquis, NICE, Pfizer, Pradaxa, apixaban, clotting
Bristol-Myers Squibb and Pfizer’s Eliquis for preventing blood clots has been shown the green light to treat venous thromboembolism (VTE), …
Acacia Pharma appoints two directors to board
March 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acacia pharma, christine soden, scott byrd
UK pharma firm Acacia Pharma that develops drugs for supportive care has confirmed Scott Byrd and Christine Soden have joined …
GlaxoSmithKline in major opium deal
March 5, 2015Sales and Marketing GSK, GlaxoSmithKline, Sun Pharma, opium, tasmania
GSK is to sell its opiates business to Sun Pharmaceuticals for an undisclosed amount, the two companies have announced. The …
Government lays out rare diseases plan
March 5, 2015Sales and Marketing Department of Health, NHS, UK, government, howe, rare diseases
The UK government has set out new plans to improve the lives of patients with rare diseases by 2020. The …
BMS’ Opdivo wins US lung cancer race
March 5, 2015Research and Development, Sales and Marketing BMS, Prostvac, biosciences, flexus, lung cancer, oncology, opdivo
The FDA has approved Bristol-Myers Squibb’s Opdivo (nivolumab) for the treatment of patients with metastatic squamous non-small cell lung cancer …
AbbVie buys Pharmacyclics in $21 billion deal
March 5, 2015Sales and Marketing AbbVie, Humira, Johnson and Johnson, Pharmacyclics, adalimumab, imbruvica
AbbVie has secured Californian biotech Pharmacyclics and beat Johnson & Johnson to gain control of blockbuster blood cancer therapy Imbruvica in …
Adaptimmune makes executive hires from GSK
March 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Adrian Rawcliffe, Rafael Amado
UK and US clinical-stage biotech firm Adaptimmune has increased its senior team with the appointment of Dr Rafael Amado as …
Eisai Alzheimer’s drug to see China review
March 4, 2015Sales and Marketing Alzheimer's, Aricept, China, Eisai, donepezil hydrochloride
Alzheimer’s drug Aricept from Eisai has been accepted for review in China to treat patients with the most severe form …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
